| 英文名称 | 中文名称 | CAS | MF |
|
Certolizumab
|
赛妥珠单抗
|
428863-50-7
|
C24H22F3N
|
|
7,7'-dibromo-9,9,9',9'-tetraoctyl-9H,9'H-2,2'-bifluorene
|
7,7'-dibromo-9,9,9',9'-tetraoctyl-9H,9'H-2,2'-bifluorene
|
428865-53-6
|
C58H80Br2
|
|
2,2-Dimethyl-1-(5-methyl-pyridin-2-yl)-propan-1-one
|
2,2-Dimethyl-1-(5-methyl-2-pyridinyl)-1-propanone
|
428866-15-3
|
C11H15NO
|
|
(7bR,10aR)-2,3,4,7b,8,9,10,10a-Octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-HI]indole hydrochloride
|
(8AR,11AR)-4,5,6,7,8A,10,11,11A-八氢-9H-环戊并[4,5]吡咯并[3,2,1-JK][1,4]苯并二氮杂卓盐酸盐
|
428868-35-3
|
C14H18N2.ClH
|
|
Fmoc-MeTyr(Bzl)-OH
|
FMOC-N-ME-TYR(BZL)-OH
|
428868-52-4
|
C32H29NO5
|
|
3-(Tetrahydro-2H-pyran-4-yl)propan-1-ol
|
TETRAHYDRO-2H-PYRAN-4-PROPANOL
|
428871-03-8
|
C8H16O2
|
|
3-Ethyl-3-hydroxypentyl methanesulfonate
|
3-乙基-3-羟戊基甲烷磺酸盐
|
428871-08-3
|
C8H18O4S
|
|
1-Piperidinecarboxylic acid, 4-[(methylsulfonyl)oxy]-, methyl ester
|
|
428871-40-3
|
C8H15NO5S
|
|
2-Amino-5-chloro-4-fluoronitrobenzene
|
2-硝基-4-氯-5-氟苯胺
|
428871-64-1
|
C6H4ClFN2O2
|
|
5-Fluoro-4-methyl-2-nitro-phenylamine
|
(5-氟-4-甲基-2-硝基-苯基)胺
|
428871-69-6
|
C7H7FN2O2
|
|
Piperazine, 1-ethyl-3-methyl- (9CI)
|
1-乙基-3-甲基-哌嗪
|
428871-71-0
|
C7H16N2
|
|
4-Amino-2-fluoro-5-nitrobenzotrifluoride
|
5-氟-2-硝基-4-三氟甲基苯胺
|
428871-73-2
|
C7H4F4N2O2
|
|
MC 1293
|
MC 1293
|
428872-06-4
|
C16H16N2O3
|
|
Ethyl (2E)-3-{1-methyl-4-[(4-methylphenyl)-carbonyl]-1H-pyrrol-2-yl}prop-2-enoate
|
(E)-3-(1-甲基-4-(4-甲基苯甲酰基)-1H-吡咯-2-基)丙烯酸乙酯
|
428872-08-6
|
C18H19NO3
|
|
R-2,2'-bis(methoxymethoxy)-3,3'-diphenyl-1,1'-Binaphthalene
|
(R)-2,2'-双(甲氧基甲氧基)-3,3'-二苯基-1,1'-联萘
|
428874-67-3
|
C36H30O4
|
|
Isothiazole, 2,3-dihydro-3-(1-methylethyl)-, 1,1-dioxide (9CI)
|
|
428879-55-4
|
C6H11NO2S
|
|
BIM-23627
|
BIM-23627
|
429619-37-4
|
C58H71ClN12O8S2
|
|
4-Formyl-2-methoxyphenyl 4-methylbenzoate
|
(4-甲烷酰-2-甲氧基-苯基)4-甲基苯甲酸酯
|
429621-85-2
|
C16H14O4
|
|
3-(5-Nitro-2-thiophene)acrylic Acid SulfadiMidine AMide
|
3-(5-Nitro-2-thiophene)acrylic Acid SulfadiMidine AMide
|
429622-48-0
|
C19H17N5O5S2
|
|
3-(4-Bromophenyl)-5-(3-nitrophenyl)-1,2,4-oxadiazole
|
3-(4-BROMOPHENYL)-5-(3-NITROPHENYL)-1,2,4-OXADIAZOLE
|
429624-16-8
|
C14H8BrN3O3
|
|
ethyl 4-[(2-chlorophenoxy)acetyl]-1-piperazinecarboxylate
|
|
429626-70-0
|
C15H19ClN2O4
|
|
N-[2-(4-fluorophenyl)ethyl]-N'-[1-(3-isopropenylphenyl)-1-methylethyl]urea
|
|
429627-68-9
|
C21H25FN2O
|
|
1-[(4-chloro-3-methylphenoxy)acetyl]piperidine
|
2-(4-Chloro-3-methylphenoxy)-1-(1-piperidinyl)ethanone
|
429628-92-2
|
C14H18ClNO2
|
|
N-(2-Chlorobenzyl)piperidine-4-carboxamide
|
N-(2-氯苄基)哌啶-4-甲酰胺
|
429631-11-8
|
C13H17ClN2O
|
|
N-(2-Furylmethyl)piperidine-4-carboxamide
|
N-(呋喃-2-基甲基)哌啶-4-甲酰胺
|
429633-39-6
|
C11H16N2O2
|
|
Piperidine-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide
|
N-[2-(吗啉-4-基)乙基]哌啶-4-甲酰胺
|
429637-00-3
|
C12H23N3O2
|
|
N-benzyl-N-ethylpiperidine-4-carboxamide
|
|
429639-61-2
|
C15H22N2O
|
|
N-{[5-(1,3-benzoxazol-2-yl)-2-methylphenyl]carbamothioyl}-3-methylbutanamide
|
|
429641-28-1
|
C20H21N3O2S
|
|
2-phenoxy-N-{[(2,4,5-trichlorophenyl)amino]carbonothioyl}acetamide
|
|
429642-01-3
|
C15H11Cl3N2O2S
|
|
1-Benzoyl-3-(2-hydroxy-5-methylphenyl)thiourea
|
N-((2-羟基-5-甲基苯基)氨基甲硫基)苯甲酰胺
|
429642-03-5
|
C15H14N2O2S
|
|
2-(4-Ethyl-phenyl)-2H-benzotriazol-5-ylamine
|
2-(4-乙基-苯基)-2H-苯并三唑-5-基胺
|
429643-68-5
|
C14H14N4
|
|
1H-Benzimidazol-2-amine,N-methyl-1-propyl-(9CI)
|
|
429646-29-7
|
C11H15N3
|
|
N-{[(2-hydroxyphenyl)amino]carbonothioyl}-3-methylbenzamide
|
|
429647-11-0
|
C15H14N2O2S
|
|
2-(3-Chloro-4-methyl-phenyl)-benzooxazol-5-ylamine
|
|
429649-92-3
|
C14H11ClN2O
|
|
N-{[(2-methoxyphenyl)amino]carbonothioyl}-2-phenylacetamide
|
|
429649-98-9
|
C16H16N2O2S
|
|
5-[(Diisopropylamino)-methyl]-furan-2-carboxylic acid
|
5-[(DIISOPROPYLAMINO)-METHYL]-FURAN-2-CARBOXYLIC ACID
|
429651-03-6
|
C12H19NO3
|
|
CHEMBRDG-BB 6608050
|
2-[2-(2-氨基苯基)乙烯基]-8-羟基喹啉
|
429651-60-5
|
C17H14N2O
|
|
5-[2-oxo-2-(1-piperidinyl)ethylidene]-1,3-thiazolidine-2,4-dione
|
|
429652-69-7
|
C10H12N2O3S
|
|
5-(5-Isopropyl-benzooxazol-2-yl)-2-methyl-phenylamine
|
|
429653-20-3
|
C17H18N2O
|
|
2-(5-Furan-2-yl-1H-pyrazol-3-yl)-naphthalen-1-ol
|
2-(5-Furan-2-yl-1H-pyrazol-3-yl)-naphthalen-1-ol
|
429653-28-1
|
C17H12N2O2
|
|
Y16
|
429653-73-6
|
429653-73-6
|
C24H20N2O3
|
|
(2-[2-(4-Methoxy-benzenesulfonyl)-ethyl]-benzoimidazol-1-yl)-acetic acid
|
{2-[2-(4-METHOXY-BENZENESULFONYL)-ETHYL]-BENZOIMIDAZOL-1-YL}-ACETIC ACID
|
429654-05-7
|
C18H18N2O5S
|
|
2-(2,4-dioxo-1,3-thiazolidin-5-ylidene)-N-(2-hydroxyphenyl)acetamide
|
|
429655-76-5
|
C11H8N2O4S
|
|
N-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)-N-(4-bromophenyl)methanesulfonamide
|
|
429656-46-2
|
C22H21BrN2O3S
|
|
Dabigatran ethyl AcOH Salt
|
达比加群乙基酯
|
429658-95-7
|
C27H29N7O3
|
|
Ethyl N-[4-(methylamino)-3-nitrobenzoyl]-N-pyridin-2-yl-β-alaninate
|
3-(4-(甲基氨基)-3-硝基-N-(吡啶-2-基)苯甲酰氨基)丙酸乙酯
|
429659-01-8
|
C18H20N4O5
|
|
4-Thiazolecarboxamide,N-cyclobutyl-2-(3-hydroxy-1-azetidinyl)-(9CI)
|
|
429668-93-9
|
C11H15N3O2S
|
|
1-Boc-3-(methoxy)azetidine
|
1-BOC-3-甲氧基基氮杂环丁烷
|
429669-07-8
|
C9H17NO3
|
|
1-Boc-3-azido-azetidine
|
1-BOC-3-叠氮基氮杂环丁烷
|
429672-02-6
|
C8H14N4O2
|
|
trans-3-Azido-1-Boc-4-methoxypyrrolidine
|
反式-3-叠氮基-4-甲氧基-吡咯烷-1-羧酸叔丁酯
|
429673-78-9
|
C10H18N4O3
|
|
trans-3-Amino-1-Boc-4-methoxypyrrolidine
|
反式-3-氨基-4-甲氧基吡咯烷-1-甲酸叔丁酯
|
429673-79-0
|
C10H20N2O3
|
|
1-Pyrrolidinecarboxylic acid, 3-hydroxy-4-(methylamino)-, 1,1-dimethylethyl ester, (3S,4S)-
|
(3S,4S)-叔丁基3-羟基-4-(甲氨基)吡咯烷-1-羧酸酯
|
429673-81-4
|
C10H20N2O3
|
|
(3S,4S)-tert-butyl 3-(tert-butoxycarbonyl(Methyl)aMino)-4-hydroxypyrrolidine-1-carboxylate
|
(3S,4S)-3-((叔丁氧羰基)(甲基)氨基)-4-羟基吡咯烷-1-羧酸叔丁酯
|
429673-82-5
|
C15H28N2O5
|
|
(3R,4R)-N-Boc-3-(benzylamino)-4-hydroxypyrrolidine
|
(3R,4R)-N-Boc-3-苄氨基-4-羟基吡咯烷
|
429673-83-6
|
C16H24N2O3
|
|
(3R,4R)-tert-butyl 3-(tert-butoxycarbonyl)-4-hydroxypyrrolidine-1-carboxylate
|
(3R,4R)-tert-butyl 3-(tert-butoxycarbonyl)-4-hydroxypyrrolidine-1-carboxylate
|
429673-85-8
|
C14H26N2O5
|
|
3-Pyrrolidinamine,4-methoxy-N-methyl-,(3R,4R)-(9CI)
|
(3R,4R)-4-甲氧基-N-甲基吡咯烷-3-胺
|
429673-86-9
|
C6H14N2O
|
|
Levetiracetam Impurity 25 HCl
|
左乙拉西坦杂质VII
|
429673-89-2
|
C8H17ClN2O3
|
|
2-Thia-5-azabicyclo[2.2.1]heptan-3-one,5-methyl-,(1S,4S)-(9CI)
|
|
429675-63-8
|
C6H9NOS
|
|
5,9-Methanoimidazo[1,5-d][1,4]oxazepine(9CI)
|
|
429676-65-3
|
C8H6N2O
|
|
CATHEPSIN G INHIBITOR I
|
CATHEPSIN G INHIBITOR I
|
429676-93-7
|
C36H33N2O6P
|
|
tert-Butyl 1-benzoylpiperidin-4-ylcarbamate
|
429677-00-9
|
429677-00-9
|
C17H24N2O3
|
|
Glycine, N-[(2R)-2-hydroxy-1-oxopropyl]-, methyl ester (9CI)
|
|
429677-97-4
|
C6H11NO4
|
|
Dichloro{(1R,2R)-N,N-bis[2-(diphenylphosphino)benzyl]cyclohexane-1,2-diamine}ruthenium(II), min. 97%
|
苄二氯{(1R,2R)- N,N -双[2 - (二苯基膦)]环己烷-1,2 - 二胺钌(II)
|
429678-11-5
|
C44H44Cl2N2P2Ru
|
|
Giberellin A14
|
|
429678-85-3
|
C19H26O5
|
|
Ethanone, 1-[2,5-dihydro-4-(2-methyl-1-propenyl)-3-furanyl]- (9CI)
|
|
429680-04-6
|
C10H14O2
|
|
4-Bromo-5-acetamidoindanone
|
4-溴-5-乙酰氨基茚酮
|
429682-68-8
|
C11H10BrNO2
|
|
4-Bromo-2-fluoro-6-methylaniline
|
4-溴-2-氟-6-甲基苯胺
|
429683-46-5
|
C7H7BrFN
|
|
Indeno[4,5-d]imidazol-6(1H)-one, 7-ethyl-7,8-dihydro- (9CI)
|
|
429683-68-1
|
C12H12N2O
|
|
Indeno[4,5-d]triazol-6(1H)-one, 7-ethyl-7,8-dihydro- (9CI)
|
|
429683-81-8
|
C11H11N3O
|
|
Methyl 6-hydroxyquinoline-2-carboxylate
|
6-羟基喹啉-2-羧酸甲酯
|
429687-75-2
|
C11H9NO3
|
|
Methyl (3R)-(-)-3-(methyl-1H-indol-3-yl&
|
(3R)-()-3-(甲基-1H-吲哚-3-基)-3-苯基丙酸甲酯
|
429689-16-7
|
C19H19NO2
|
|
(S)-Methyl-3-(1-methyl-1H-indol-3-yl)-phenyl-propionate
|
(3S)-(+)-3-(甲基-1H-吲哚-3-基)-3-苯丙酸甲酯
|
429689-17-8
|
C19H19NO2
|
|
(R)-Methyl-3-(1-methyl-1H-indol-3-yl)-phenyl-propionate
|
(R)-METHYL-3-(1-METHYL-1H-INDOL-3-YL)-PHENYL-PROPIONATE
|
429689-18-9
|
C19H19NO2
|
|
(3R)-(+)-3-(1-Methyl-1H-indol-3-yl)buta&
|
(3R)-(+)-3-(1-甲基-1H-吲哚-3-基)丁腈
|
429689-23-6
|
C13H14N2
|
|
(3S)-(-)-3-(1-Methyl-1H-indol-3-yl)butanenitrile
|
(3S)-(-)-3-(1-甲基-1H-吲哚-3-基)丁腈
|
429689-24-7
|
C13H14N2
|
|
(3R)-3-(1-Methyl-1H-indol-3-yl)-3-pheny&
|
(3R)-3-(1-甲基-1H-吲哚-3-基)-3-苯基丙腈
|
429689-25-8
|
C18H16N2
|
|
ethyl 3-bromoH-imidazo[1,2-a]pyridine-5-carboxylate
|
3-溴咪唑[1,2-A]吡啶-5-羧酸乙酯
|
429690-42-6
|
C10H9BrN2O2
|
|
IMidazo[1,2-a]pyridine-5-carboxaldehyde, 3-broMo-
|
3-溴代咪唑并[1,2-A]吡啶-5-甲醛
|
429690-43-7
|
C8H5BrN2O
|
|
IMidazo[1,2-a]pyridine-5-carboxaldehyde, 3-nitro-
|
|
429690-44-8
|
C8H5N3O3
|
|
Faropenem Related Compound 2
|
Faropenem Related Compound 2
|
429691-43-0
|
C21H33NO7SSi
|
|
(2S,2'S)-2,2'-(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl)dipropanoic acid
|
(2S,2'S)-2,2'-(1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl)dipropanoic acid
|
429692-85-3
|
C20H14N2O8
|
|
Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone,2,7-bis(2H-tetrazol-5-yl)-
|
N?N-?DI(5-?四唑基)?-?1.?4.?5.?8-?萘四甲氧基二亚胺
|
429693-19-6
|
C16H6N10O4
|
|
2-Butanone, 3-[(3-aminopropyl)imino]-, (3E)- (9CI)
|
|
430424-18-3
|
C7H14N2O
|
|
2-Butanone, 3-[(3-aminopropyl)imino]-, (3Z)- (9CI)
|
|
430424-19-4
|
C7H14N2O
|
|
IWR-1/IWR1
|
4-(1,3,3A,4,7,7A-六氢-1,3-二氧代-4,7-甲桥-2H-异吲哚-2-基)-N-8-喹啉基苯甲酰胺
|
430429-02-0
|
C25H19N3O3
|
|
2'-Iodo-2-phenylacetophenone
|
1-(2-碘苯基)-2-苯基乙烷-1-酮
|
430429-42-8
|
C14H11IO
|
|
430429-71-3
|
430429-71-3
|
430429-71-3
|
C9H14O2
|
|
5,8,11-Trioxa-12-thia-2-azatridecanoic acid, 1,1-dimethylethyl ester, 12,12-dioxide
|
氨基叔丁酯-三聚乙二醇-MS
|
430430-57-2
|
C12H25NO7S
|
|
Methanediol, (4-fluoro-3-methylphenyl)- (9CI)
|
|
430431-53-1
|
C8H9FO2
|
|
Methanediol, (3-fluoro-4-methylphenyl)- (9CI)
|
|
430431-55-3
|
C8H9FO2
|
|
2-{[(4-Bromophenyl)amino]methyl}-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3-dione
|
4-[(4-溴-苯基氨基)-甲基]-4-氮杂-三环[5.2.1.0(2,6)]癸-8-烯-3,5-二酮
|
430432-41-0
|
C16H15BrN2O2
|
|
Berberine Impurity 1
|
Berberine Impurity 1
|
430433-40-2
|
C18H22ClNO4
|
|
L-Leucyl-L-alanine hydrate
|
L-LEUCYL-L-ALANINE HYDRATE
|
430434-29-0
|
C9H20N2O4
|
|
Inulin, carboxymethyl ether, sodium salt
|
菊粉钠
|
430439-54-6
|
|
|
NCS-SODIUM SALT HYDRATE, >= 98% HPLC
|
化合物 NCS-356 SODIUM
|
430440-66-7
|
C10H9ClO3.Na
|
|
2,4-Dichloro-6-(chloroMethyl)-5-MethylpyriMidine
|
2,4-二氯-6-(氯甲基)-5-甲基嘧啶
|
430440-91-8
|
C6H5Cl3N2
|
|
N-{[(2-methoxyphenyl)amino]carbonothioyl}-2,2-diphenylacetamide
|
|
430441-58-0
|
C22H20N2O2S
|
|
4-(1H-Indol-3-yl)-5-methyl-thiazol-2-ylamine
|
4-(1H-INDOL-3-YL)-5-METHYL-THIAZOL-2-YLAMINE
|
430442-17-4
|
C12H11N3S
|
|
2-chloro-5-iodo-N-(pyridin-3-ylcarbamothioyl)benzamide
|
|
430443-14-4
|
C13H9ClIN3OS
|
|
Ethanone, 1-(3,4-dihydroxyphenyl)-2-[[3-(2-furanyl)-1H-1,2,4-triazol-5-yl]thio]-
|
1-(3,4-二羟基苯基)-2-(5-(呋喃-2-基)-4H-1,2,4-三唑-3-基硫基)乙酮
|
430444-03-4
|
C14H11N3O4S
|